Drug Database
Back to search

Japan· JP-3999069M3026

パロバロテン

A palovarotene product containing パロバロテン, registered in Japan by ＩＰＳＥＮ, on the national reimbursement list. The same ATC class is registered in 3 of our 19 countries.

On Japan’s NHI price listATC M09AX11

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedパロバロテンATCM09AX11REGISTER NO.JP-3999069M3026PACKS LISTED0CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about パロバロテンAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Palovarotene is registered in 3 of 19 countries.

Countries holding a registration under ATC M09AX11 (palovarotene), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 1 of them publish a price we can compare per daily dose
Search palovarotene products by name

Palovarotene · ATC M09AX11

3 / 19 countries

  • Canada
  • Japan
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

MHLW / PMDA (Japan)
Active substance
パロバロテン
Manufacturer
ＩＰＳＥＮ
Country
Japan (JP)
ATC code
M09AX11
ATC class
Palovarotene
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under M09AX11

Palovarotene, as other registers publish it.

All palovarotene products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b1dc0fe5-f2e5-4a83-b54f-1ec60387535c
GET /v1/drugs/b1dc0fe5-f2e5-4a83-b54f-1ec60387535c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "２．５ｍｇ１カプセル",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "3999069M3026",
  "category": "内用薬",
  "price_yen": 9567,
  "generic_name": "パロバロテン",
  "product_name_jp": null,
  "therapeutic_class": "3999",
  "transitional_expiry": "9567"
}
API referenceMCP serverPlans

See everything about palovarotene.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console